Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FHPXC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,363
Award facts
- Contract value 100% obligated
- $26,362.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,362.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion deadline of June 2, 2025. This non-set-aside competitive award was issued on May 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used anti-nausea medication widely utilized in military and veteran healthcare systems for chemotherapy side effect management, post-operative recovery, and other medical applications.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency, supplying critical medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FHPXC?
SPE2DB25FHPXC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FHPXC worth?
The government has obligated $26,363 on SPE2DB25FHPXC.
Is contract SPE2DB25FHPXC an order under another contract?
Yes. SPE2DB25FHPXC is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHPXC competed?
The extent of competition for SPE2DB25FHPXC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award